Paul Frankenbach/LinkedIn
Sep 2, 2026, 17:22
Paul Frankenbach: New Insights into the Signaling Pathways of Antiphospholipid Antibodies at ISTH 2026
Paul Frankenbach, PhD Candidate at University Medical Center Mainz, shared a post on LinkedIn:
”I had the opportunity to present my research on the critical signaling pathways of different antiphospholipid antibodies at the International Society on Thrombosis and Haemostasis (ISTH) in Paris.
I am very grateful for the support from my supervisors Nadine Müller-Calleja and Wolfram Ruf, my co-authors and the DFG!
It was wonderful to connect with so many experts, exchange ideas, find new friends, and receive valuable feedback on my work.
Looking forward to continuing these discussions in the coming years!”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment